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ABSTRACT 
This paper presents the insight that R&D investments are "natural" op-
tionM , and examines the extent to which they can be valued using currently 
Available option pricing models. The nature of the industrial research effort 
determi nes whether the appropriate model is based on a diffusion process or a 
jump process. The option model based on the former is sufficiently developed 
to eatisfactorily deal with the direct benefits of R&D, while the model based 
on t he l atter presents several problems. Furthermore, indirect benefits are 
not captured in these models. These applications and shortcomings are ex-
amined in deta il in the hope of not only indica ting a new direction f or analy-
111 of R&D investment decisions, but also pointing out the need for further 
ICholarly research to deal more fully with this very interesting problem. 
BUDGETING CAPITAL FOR R & D: AN APPLICATION OF OPTION PRICING 
Introduction: 
Deciding where and how much to invest in industrial research and devel-
opment is not only a very interesting problem, but also one of great import-
ance-- in 1977 the total U. S. R&D pricetag topped $40 billion.! In 1976 the 
top three private spenders -- General Motors, IBM, and Ford -- alone accounted 
for $3.2 billion.2 R&D investment is big, and it is hard to picture a vital, 
dynamic economy without such venturing. 
We have ample evidence that there is a systematic relationship between 
profitability and the level of committment to R&D;3 however, there is a seri-
ous shortcoming in the way of rigorous methods to show what level is best for 
a particular situation, as even the most sophisticated optimization models 
suffer when benefit estimates are soft.4 
There are several mathematical models available, some very complex, for 
optimizing the R&D project mix, but as pointed out by Baker & Freeland [4] in 
their review of the literature, measuring the benefits from R&D is a critical 
area for further research. The best of the available approaches depend on an 
estimate of cash flows from the successful project. However, it is difficult 
or impossible to analysis R&D expenditure using any of the standard capital 
budgeting techniques which discount expected future cash flows from the pro-
ject. The very reason for research is that much is unknown about the fledg-
ling product or technology; for example, it might be unreasonable to make an 
estimate of cash flows prior to embarking on research into, say, commerical 
applications of solar-powered electric generation. Even if such estimates 
were made, it would be equally difficult to estimate the appropriate required 
rate of return to be used as the decision criterion. In many cases it is 
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difficult to confidently estimate an appropriate beta, or deal with the corre-
lations between the new project and existing projects within the firm's port-
folio. Moreover, it is the nature of research that new information is being 
sought which may have a profound impact on the value of the project. 
What is being bought with research money is opportunity -- opportunity to 
exploit any marketable results of the research. In its simplest aspect, the 
decision facing the business strategist is whether or not the value of the op-
portunity exceeds the cost. Fortunately, a tool exists which may allow the 
necessary cost-benefit comparison to be made in a disciplined way: the Option 
Pricing Model (OPM). An R&D opportunity is a "natural" option; the funding of 
research is the purchase of an option to exploit any product which might re-
sult. 
Discussion of the Problem: 
Consider the executive faced with deciding whether to fund a particular 
project . He probably has fairly reliable estimates of the cost of research, 
but no guarantee that any return will come from "casting his bread upon the 
waters. " If the potential is great enough, he will give the go-ahead knowing 
that if only one out of every ten of thes e high-flyers pays off, the company 
will still come out ahead. He also knows that if the business doe sn't take 
risks, it will go stale. 
The direct benef it from a successful R&D effort would come from the op-
portunity to exploit a new pr oduct with competition held at bay by patents or 
delays in developing their own substitutes. This can be dealt with as an op-
tion. The option framework is intuitively a very attractive place to look f or 
a solution, as the decision face d by the executive above is similar to that 
faced by an investor considering purchase of a call option. The execut ive 
mu1t pay a price to get into a game in which there may be no payoff at all; 
however , the attraction is the chance for a really big payoff. 
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The price of conducting research buys the investor the opportunity to ex-
ploi t a ny product which might result, and can be thought of as an option to 
make a n investment in production. This concept could be modeled in such a way 
that the underlying thing of value is the present value of revenues from pro-
duction, the exercise. price is the cost of initiating production, and the ex-
pira t i on date is the time the money runs out from the initial research invest-
ment . Although this approach raises the complication of a stochastic exercise 
price , the problem is addressable in a straight-forward manner as shown by 
Stanley Fischer [18]. 
An appropriate model would incorporate an initial cost of the option 
equal to the present value of the cost of conducting research over a particu:.... 
lar period of time, discounted at the risk-free rate;S an expiration date co-
i nc i ding with exhaustion of the fund set up by the initial investment, as well 
as an underlying thing of value and exercise price which follow stochastic 
processes through time. Upon exhaustion of the original money invested, fur-
t he r research or development might appear attractive; and this could be treat-
ed as a separate investment in a new option. 
The decision variables for executives are the size of the initial invest-
ment and the length of time to be funded at each decision point (in other 
wor ds, the number of times the research effort must be reevaluated). 
Initiating product research is the setting in motion of an information-
gathering process. At the outset, the research management team brings to bear 
a ll the currently available information about the prospects for the research, 
and this information is reflected in their initial estimate of the project's 
value. Once research is under way, new information surfaces continuously and 
--- - - -
- ··-- --- --
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the value estimate is revised accordingly. It is a matter of uncertainty ex-
actly where the research will lead, but the range of uncertainty~ be esti-
mated ahead of time and the process modeled statistically. 
The option investor however can do something our corporate executive can-
not so easily do -- the option investor can hedge. By judiciously selling 
short the underlying stock, the holder of a call option can theoretically eli-
minate risk altogether. However, when the underlying thing of value is an un-
developed product or technology, such hedging is not available. This point is 
important primarily from the standpoint of modeling. Many, perhaps most, op-
tion investors play the game because options offer them a way to take the high 
levels of risk that justify the long-run expectation of high reward. These 
folks are not interested in forming riskless hedges. However, the possibility 
of doing so allows arbitrage, and the hedge is key to the Black-Scholes market 
equilibrium solution to the value of an option. 
Although the stochastic calculus used in the OPM is sophisticated, the 
basic idea is simple. Because there is a direct relationship between the val-
ue of a call option and the value of its underlying security, there is perfect 
negative correlation between returns to a call and returns to a short position 
in the stock. It is theref ore possible to form a riskless hedge position, and 
in capital market equilibrium the return on the hedge must be the same as the 
return on other risk- free investments. By expressing this hedge in a dynamic 
continuous time set of equations, Black and Scholes [6] were able to derive a 
solution for the value of the call option. The finance literature contains 
several good reviews of option pricing, for the reader interested in full de-
tails. 6 
The lack of hedging opportunit i es puts the R&D executive's problem in a 
different light; the company will not necessarily have to pay the full 
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equilibrium value to get in on the action. Not only is the company not buying 
into the gamble on an active and efficient securities market, but even if that 
were the case, there would be no opportunity for arbitrageurs to enforce the 
going market reward for risk by the method of forming hedges. The option 
pricing model is nevertheless applicable, because the active option market 
represents an alternative opportunity to provide risk-bearing services of the 
same kind. The OPM can give insight into what the market equilibrium value 
should be for a particular venture, and if it could be bought for that amount 
or less, it would be a good investment. 
Diffusion Process Models: 
The assumptions made at the outset (about the appropriate stochastic pro-
cess underlying the project value) determine which option pricing model will 
be used. Research intended to improve on an existing product or process might 
fit into the framework of a diffusion process. The essence of a diffusion 
process is that it represents a continuous random walk around a trend and, at 
least in the short run, seldom offers sudden surprises. The basic assumption 
of the Black-Scholes OPM is that the value of the underlying security follows 
a log-normal diffusion process expressed as, 
(1) 
where S is the value of the underlying security, ~ is the drift term, as is 
the instantaneous standard deviation around the drift, and dzs is a Weiner 
process. A Weiner process describes Brownian motion, which can be illustrated 
by the movement of a very small particle suspended in a fluid and bombarded at 
random by moving molecules. Each movement is small, the bombardment is con-
tinuous, and the two- dimensional analogue of the path is a random walk. 
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There are many research projects whose value would change through time in 
the same way. This would be the case if the product or process being 
researched were already well-developed, the goal of the research well-defined, 
and the obstacles to be overcome fairly well-known in advance. The majority 
of R&D money is spent on such projects.? In short, such research would be 
expected to produce a steady upward trend, with random shocks along the way 
which individually would most likely be small. In the short run, no great 
surprises would be expected; but even so, the final outcome could not be known 
in advance with certainty. 
The nature of the random shocks themselves is worth further discussion. 
Random upward boosts of course could result from fortuitous discoveries, and 
unforeseen bottlenecks could produce downward shoves of enough magnitude to 
dampen or cancel out the upward drift. Would it, however, be realistic to 
leave the model free to capture an actual decline in the value of the product 
or process? In other words, it seems fair to ask whether the time path should 
be restricted to upward movement only. It could be possible that the research 
would reveal previously unknown flaws in the idea, and it is also desireable 
to allow for external events (such as competition or the possibility of prQ-
duct liability suits) which could have an adverse impact on the value of the 
product. It therefore seems reasonable to leave as is the specification pre-
sented in equation (1). 
From equation (1), Black and Scholes developed a formula for the equilib-
rium value of a call option with a known exercise price. If the cost of im-
plementing the changes resulting from the research (the striking price for ex-
ercising the research option) were known with certainty beforehand, the basic 
Black-Scholes model could be used unmodified. It is stated as follows: 
t 
c S • N lln (S/X) + [r + (cr 2 /2)] T( 
cr{T J 
-rT • N [ ln 
-e X 
(S/X) + [r - (cr 2 /2)] T ? 








N { • } 
call option price 
current stock price 
exercise price 
default-free interest rate 
instantaneous variance of return on the stock 
time to expiration 
cumulative normal distribution function 
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(2) 
However, it may be more realistic to suppose that the exer_cise price is 
not known with certainty beforehand. In such a case it would be possible to 
make an initial estimate of it, with st·ochastic changes anticipated. In the 
case where the exercise price also follows a diffusion process, a solution ex-
ists as presented by Stanley Fischer [18]. Where new information impacting on 
the initial estimate of exercise price is assumed to come in random, continu-
ous small jolts, the process generating the time path for it could be des-
cribed by the following equation: 
(3) 
where X is the exercise price, ax is a drift term, crx is the instantaneous 
standard deviation, and dzx is a Weiner process. 
In the R&D case, it would be valid to assume that no drift would be 
expected, so that ax would be zero. Modifying Fischer's equation accordingly, 
the market equilibrium value would be, 
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)ln(S/X) + "'2 /2)]T) c S • N [rh + (o 
1. "' ·~ a{T ) 
( ln( S/X) "'2 /2)]T t 
-xe-rt • N + [rh - (o (4) ). 
' h ( [T j a 
2 2 "'2 
where a o8 - ox - 2asaxPsx• The parameter a is the instantaneous propor-
tiona! variance of change in the ratio (S/X). The parameter rh is the rate of 
return on the (possibly imaginary) security used to hedge away the risk from 
the fluctuating exercise price. The expected return on this hypothetical se-
curity would be given by: 
rh = r + b (5) 
where r is the risk-free rate and b is the appropriate risk premium. Applying 
the Capital Asset Pricing Model to establish the appropriate value for b re-
sults in the following: 
( 6) 
where t~e subscript m denotes the market as a whole. Thus, when Pmx = 0, b 
is also zero. In most cases of R&D, the correlation between random shocks to 
the stock market and random shocks to the exercise price would be nonexistent. 
That is, the risk associated with the exercise price in the R&D case is in all 
likelihood based on technological uncertainties which are completely unsys-
tematic and therefore diversifiable.8 Thus, rh would be , in this case, the 
risk-free rate. 
It may be that in the real world, opportunities do not exist to form the 
hedges assumed in the derivation of the option pricing models; nevertheless, 
the models are valuable and applicable. 
f 
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Surely the basic justification for the existence of a business organiza-
tion is that it can exploit imperfections in the markets for goods and 
services which the individual investor cannot do alone. Unless the managers 
can find investments which offer a return to risk ratio at least as favorable 
as that available to the capital market investor, the organization cannot pay 
the freight and will not long exist. Security valuation models can therefore 
be used as a benchmark for evaluating the corporation's investments, in that 
they show the appropriate reward for a given kind and level of risk. 
The wide availability of software for the Black-Scholes OPM (even for 
hand-held calculators) makes its adaptation for estimating the benefits from 
R&D projects very attractive. It is a model with a proven track record, which 
is reassuring to decision-makers. To set up for its use, the analyst needs 
estimates of only seven inputs: 
s = an initial estimate of the present value of cash flows from 
the product or process to be developed 
X = an initial estimate of the cost of undertaking production 
r = the risk-free interest rate 
as = the instantaneous standard deviation around the trend line for S 
ax = the standard deviation around the trend line for X 
Psx = the correlation between random shocks to S and X 
T = time to expiration of the research effort 
These estimates could be made subjectively for each project, or objectively on 
the basis of historical data for similar projects previously undertaken. The 
making of these estimates, especially that for S, interfaces the model with 
the expertise of the R&D planning staff. The inability of existing mathemati-
cal models to do this adequately has been an area of past criticism.9 
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Not only is equation (4) useful for estimating the value of initiating 
research, it can also give insight into the decision about the length of time 
for which the research should be funded. One of the results from option pric-
ing theory is that the value of the option increases the longer the time to 
expiration.10 Intuitively, this can be explained because the longer the time 
the process has in which to operate, the greater the potential spread between 
exercise price and the value of the underlying security. ~~nagers could use 
the model to see the results of various decisions about T, and could choose 
accordingly. 
An Implication of the Diffusion Model 
One remarkable fact from option pricing theory is that because of the 
limited liability of the option (so that the downside is truncated) the option 
is more valuable the higher the variance of return on the und e rlying security. 
Increasing the variance, ceteris paribus, means an increase in upside poten-
tial, but the limited liability prevents downside risk from increasing propor-
tionately -- thus the increase in the value of the option. Translated into 
the R&D ~ield, this means that the greater the uncertainty about what the re-
search will discover, the greater the value of that research. The somewhat 
troubling implication which naturally follows is that so long as this holds 
true, society need have little worry about the prospects for continued techno-
logical progress. This runs contrary to the malaise perceived by many to be 
currently afflicting industrial research in the United States. 
Barring an unlikely lack of research opportunities (resting on the fool-
ish notion that there is little left to invent), the malaise could be traced 
within the confines of the model to low perceived value for the underlying 
securities. This would be the natural result of long delays imposed by 
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government regulatory bodies between the time research has produced a product 
and the time that product can be marketed. In the drug industry, for example, 
such delays are necessary for testing the safety of new drugs. Also of con-
cern would be a political climate hostile to the apparently large profits of 
successful development efforts, which is an especially important possibility 
in the fields of food, fuel, and medicine. Finally, the increased risk of 
product liability litigation in the current business environment certainly 
adds a dimension capable of greatly reducing the expected value of going ahead 
with production, therefore reducing the incentive for research. 
In order for a society to progress, it is necessary that risks be taken, 
and that risk-takers be rewarded. During the formative years of this nation, 
large numbers of very ordinary people were willing to take the ultimate risk 
necessary to settle the frontiers. Progress depends not only on the taking of 
financial risks, but also on the taking of technological and even physical 
risks. Those willing to bear these risks serve an essential role, and are 
compensated by the hope of a better life. Yet, as more people share in a 
high-quality life, it may be that fewer are willing to bear non-financial 
risk; and we more often call into question the fairness of the circumstances 
out of which such risk-taking arises. 
Not only business firms, but also governments and nations must be compe-
titive. It is to be expected that the less risk-averse groups will be the 
centers of innovative activity, and that they will tend to progress more rap-
idly. 
The Problem of Indirect Benefits 
The benefits from R&D are complex and subtle. Besides the direct bene-
fit, indirect benefits from an ongoing R&D effort could come from chance 
12 
discoveries or perhaps more importantly from the know-how in place to re s pond 
to breakthroughs in technology achieved elsewhere. Because the option model 
just presented does not capture the s e indirect benefits, it is possible that 
research projects which should be a ccepted would be erroneous ly rejected if 
the OPM were used as the sole criterion. 
Another interest ing problem with indirect benefits c oncerns the model's 
basic underlying a ssumption about the value of the information whi c h creates 
the c hanges in t he pri c e of the underlying s ecurity. W"h e n dealing with 
stocks, the use of a log-normal diffu s ion process grows out of the assumption 
of an efficient market, within which the security ' s price changes in respons e 
to new information (whi c h c omes at random). Once the n ew information ha s been 
captured in the price of the underly ing stock, the information has no more 
value. The initiation of indus trial research se t s in motion a s imilar inf or-
mation generating pro c ess and this information adj u sts the e s timated value of 
the underlying securit y , but it i s not necessarily true that the inf ormation 
then be c ome s worthles s . Any residual value o f the information is another in-
direct benefit not c apture d in s traight f orward appli ca tion o f the OPM to the 
R&D problem. If the value o f direct benefit s were e noug h to j u s ti fy the ini-
tiation of research, c ons ideration o f indirect benefit s would be a moot point 
for the decision-maker (although not f or the securities analys t). From the 
decision-maker's point of v iew, the OPH ca n only give a c lear "go" indi c ation 
for the R&D decis ion, but cannot be relied upon alone f or a "no-go" choice. 
Even though the problem of indi rect be ne f it s thus limit s it s u sefulness , the 
OPM still can gi ve a c lear indi cat ion in one di rec t i on, and s o is not without 
value in a pplicat ion t o the R&D proble m. Mo re over , d e s pite it s d rawba c k s , it 
captures more o f the value o f R&D than any of the di scounte d c a s h fl ow tech-
niques whic h represent the c urrent s tate-of -the-art. 
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Placing a value on these indirect benefits is a pregnant area for further 
scholarly research. 
Problems with the Jump Process Model: 
In the framework of the diffusion process, it is possible to deal with 
situations characterized by slow, steady change. There are no sudden leaps 
expected, although they can occur and are allowed for in the variance of the 
diffusion process (although most moves cluster around the mean, allowance is 
implicitly made for the occassional very large jump). There are R&D situa-
tions, however, in which sudden leaps are the essence rather than the excep-
tion. In fact, the exciting projects dealing with things on the frontiers of 
science and technology would not fit very neatly into the diffusion process 
scenario. In this exciting world of high-technology research, days -- even 
weeks -- can go by with no apparent progress; then suddenly a barrier comes 
down and a great leap is accomplished in but a moment of time. There is a 
continuous time stochastic process, the jump process, which captures this. 
Unfortunately, application of the available jump process option model to R&D 
is much less satisfying than application of diffusion process models. 
Cox and Ross [14] have worked out market equilibrium solutions to option 
values under a variety of stochastic processes, including jump processes. If 
x denotes the current state of the world, then a general form for a Markov 
jump process can be stated as: 
A (x)dt k (x) -1, 







= probability of jump during time interval dt, or the process 
intensity 
= jump amplitude 
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Cox and Ross showed that the diffusion process of equation (1) is actual-
ly a special case of the more general process of equation (7). Unlike the R&D 
scenario which fit equation (1), the case now being dealt with is one which 
contains no drift. As noted above, a long time may go by with no apparent 
progress. Thus, the drift term would drop out. However; several other, more 
restrictive assumptions are necessary to derive a workable solution. By as-
suming that any discoveries would be good news, the jump direction would have 
to be up and the term [k(x) - 1] can be confined to positive values. This is 
necessary to prevent violation of the limited liability condition. Further, 
if it were assumed that all knowledge about the current state of the world 
were captured in the initial estimate of the project's value, S, then A.(x) and 
k(x) could be restated as A.(S) and k(S). Finally, if the process intensity 
A.(x) were specialized to be proportional to S, A.S, and the amplitude assumed 
to be independent of S, the process would be refined to one for which Cox & 
Ross have accomplished a market equilibrium solution. It is a pure birth pro-
cess without drift, 
A.Sdt k-1, 
dS 
o. ( 8) 
Unfortunately, a solution has not yet been found for the situation in which 
the jump amplitude can take more than one value, because it greatly compli-
cates formation of the hedge necessary to specify the market equilibrium con-
dition, and because it allows the possibility that the limited liability con-
straint might be violated. Even so, theLe is no practical difference between 
a single large jump and a rapid-fire series of small jumps, which could occur 
under the above specification. The valuation formula derived under the pure 
birth process is given by Cox & Ross as follows: 
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C = S • }. B (j; k~1 + 1, e-r(T-t)) 
j)[X/(k-1) +2] 
~ xe-r(T-t) • L B (j; s k-1 0-r(T-t)) ( 9) 
j){E/k-1 +1] 
Notation: 
C value of option 
S value of underlying security 
X exercise price 
k = jump amplitude 
T time of expiration 
t = current time 
r = risk-free rate 
B(j;p,q) ( j-1) qP (1-q)j-p the negative binomial distribution, with 
p-1 
values for j and p adjusted to the largest integer not ex-
ceeding the orginal value. 
To implement the use of this technique, the analyst would need point es-
timates for S,X,k, and r based on the best currently available knowledge. Un-
fortunately, a solution has not yet been worked out which allows the exercise 
price to be stochastic. 
As Cox and Ross pointed out, the market equilibrium solution is indepen-
dent of A, the process intensity. This is because within the hedge portfolio 
of stock and option postulated for the arbitrageur, jumps cancel each other 
out. It is not the frequency of jumps but the size of them which determines 
the option's value within such a hedge. This presents a problem when there is 
uncertainty about the jump amplitude. As pointed out in the discussion of 
FOOTNOTES 
l. Source: National Science Foundation report, "National Patterns of R&D Re-
sources, 1953-1977." The 1977 total was estimated at $40.8 billion,up 9% 
from the $37.3 billion in 1976. Of the total, $5.2 billion was for basic 
research, $9.0 billion for applied research, and $26.6 billion for develop-
ment. Of the total estimate, 53% was for federally-funded projects --the 
majority devoted to space and defense. 
2. Source: Business Week survey published in the June 27, 1977 issue, pp. 62-
64. 
3. See Branch 17), Clarkson [9), Grabowski & Mueller [24), Leonard [29), 
Scherer [43), Schwartzman [47), Severn& Laurence [48), and Worley [53). 
4. See Baker and Freeland [4), p. 1169, "In summary, despite the large number 
of benefit measurement models in the literature, relatively little is known 
about the performance of these models when applied within an R&D environ-
ment. This is a critical area for future research." 
5. The risk-free rate is recommended here because risk is being handled through 
the OPM. The money committed to research represents a voluntary obliga-
tion, and the amount of the outflow is assumed to be fixed ahead of time 
with certainty. 
6. Perhaps the best published review is that by Clifford Smith [51). 
7. See data in note 1. Of the 1977 total, 65% was for product development; 
only 12.7% was for basic research. 
8. The uncertainty about the exercise price arises from technological matters. 
There is little ~ priori reason to believe that there should be a systemat-
ic relationship between such things and the market as a whole. 
9. See Baker & Freeland [4), p. 1165, where available models were criti-
cized for "no explicit recognition and incorporation of the experience and 
knowledge of the R&D manager." 
10. See Smith [51] for proof. 
11. That is, all the company stands to lose is the research investment. 
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